Home

search

Subjectguide
Journals
Books / Serials / Multimedia
Services
Services

Login for Subscribers
Logout

Sitemap
Help
Contacts


Logo






Vol. 20, No. 1, 2005   

Free Abstract     Article (References)     Article (PDF 115 KB)     
Free Access

Original Research Article

Supplemental Use of Antioxidant Vitamins and Subsequent Risk of Cognitive Decline and Dementia
Colleen J. Maxwella, b, Matthew S. Hicksa, David B. Hogana-c, Jenny Basranb, Erika M. Eblyc

Departments of
aCommunity Health Sciences,
bMedicine, and
cClinical Neurosciences, University of Calgary, Calgary, Canada

Address of Corresponding Author

Dement Geriatr Cogn Disord 2005;20:45-51 (DOI: 10.1159/000085074)


 goto top of page Key Words

  • Antioxidant vitamins
  • Cognitive decline
  • Dementia
  • Vascular cognitive impairment
  • Alzheimer's disease

 goto top of page Abstract

There are conflicting reports about the potential role of vitamin antioxidants in preventing and/or slowing the progression of various forms of cognitive impairment including Alzheimer's disease (AD). We examined longitudinal data from the Canadian Study of Health and Aging, a population-based, prospective 5-year investigation of the epidemiology of dementia among Canadians aged 65+ years. Our primary objective was to examine the association between supplemental use of antioxidant vitamins and subsequent risk of significant cognitive decline (decrease in 3MS score of 10 points or more) among subjects with no evidence of dementia at baseline (n = 894). We also explored the relationship between vitamin supplement use and incident vascular cognitive impairment (VCI; including a diagnosis of vascular dementia, possible AD with vascular components and VCI but not dementia), dementia (all cases) and AD. After adjusting for potential confounding factors assessed at baseline, subjects reporting a combined use of vitamin E and C supplements and/or multivitamin consumption at baseline were significantly less likely (adjusted OR 0.51; 95% CI 0.29-0.90) to experience significant cognitive decline during a 5-year follow-up period. Subjects reporting any antioxidant vitamin use at baseline also showed a significantly lower risk for incident VCI (adjusted OR 0.34, 95% CI 0.13-0.89). A reduced risk for incident dementia or AD was not observed. Our findings suggest a possible protective effect for antioxidant vitamins in relation to cognitive decline but randomized controlled trials are required for confirmation.

Copyright © 2005 S. Karger AG, Basel


 goto top of page Author Contacts

Dr. Colleen Maxwell
Community Health Sciences, University of Calgary
Heritage Medical Research Building, 3330 Hospital Drive N.W.
Calgary, Alberta T2N 4N1 (Canada)
Tel. +1 403 220 6557, Fax +1 403 270 7307, E-Mail maxwell@ucalgary.ca


 goto top of page Article Information

Accepted: December 17, 2004
Published online: April 12, 2005
Number of Print Pages : 7
Number of Figures : 0, Number of Tables : 2, Number of References : 26

 
Journal Home
Journal Content
Guidelines
Editorial Board
Aims and Scope
Subscriptions
Medline Abstract (ID 15832036)
Download Citation
Cited In



This journal is part of the first subject package of the Karger

Journal Archive Collection

Information on packages (PDF)
Free sample issues


For non-native English speakers and international authors who would like assistance with their writing before submission, we suggest American Journal Experts for their scientific editing service.




copyright  © 2009 S. Karger AG, Basel